CN105476020B - 一种维生素d3软胶囊及其制备方法 - Google Patents
一种维生素d3软胶囊及其制备方法 Download PDFInfo
- Publication number
- CN105476020B CN105476020B CN201510859340.4A CN201510859340A CN105476020B CN 105476020 B CN105476020 B CN 105476020B CN 201510859340 A CN201510859340 A CN 201510859340A CN 105476020 B CN105476020 B CN 105476020B
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- soft capsule
- seed oil
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000011782 vitamin Substances 0.000 title claims abstract description 10
- 229940088594 vitamin Drugs 0.000 title claims abstract description 7
- 229930003231 vitamin Natural products 0.000 title claims abstract description 7
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 7
- 150000003722 vitamin derivatives Chemical class 0.000 title claims abstract description 7
- 239000002775 capsule Substances 0.000 title claims description 9
- 239000007901 soft capsule Substances 0.000 claims abstract description 67
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 40
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 40
- 239000011710 vitamin D Substances 0.000 claims abstract description 40
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 40
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 40
- 229940046008 vitamin d Drugs 0.000 claims abstract description 40
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 38
- 239000011647 vitamin D3 Substances 0.000 claims abstract description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 26
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 108010010803 Gelatin Proteins 0.000 claims abstract description 23
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 23
- 229920000159 gelatin Polymers 0.000 claims abstract description 23
- 239000008273 gelatin Substances 0.000 claims abstract description 23
- 235000019322 gelatine Nutrition 0.000 claims abstract description 23
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 23
- 239000003381 stabilizer Substances 0.000 claims abstract description 23
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 22
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 22
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims abstract description 20
- 239000001354 calcium citrate Substances 0.000 claims abstract description 20
- 235000013337 tricalcium citrate Nutrition 0.000 claims abstract description 20
- 150000001413 amino acids Chemical class 0.000 claims abstract description 18
- 239000011653 vitamin D2 Substances 0.000 claims abstract description 16
- 235000001014 amino acid Nutrition 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000019498 Walnut oil Nutrition 0.000 claims abstract description 13
- 235000011187 glycerol Nutrition 0.000 claims abstract description 13
- 239000008213 purified water Substances 0.000 claims abstract description 13
- 239000008170 walnut oil Substances 0.000 claims abstract description 13
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 11
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims abstract description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 28
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 26
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 244000237330 gutta percha tree Species 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 229930003427 Vitamin E Natural products 0.000 claims description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 14
- 235000019165 vitamin E Nutrition 0.000 claims description 14
- 229940046009 vitamin E Drugs 0.000 claims description 14
- 239000011709 vitamin E Substances 0.000 claims description 14
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 13
- 229930003268 Vitamin C Natural products 0.000 claims description 13
- 239000003921 oil Substances 0.000 claims description 13
- 235000019198 oils Nutrition 0.000 claims description 13
- 235000019154 vitamin C Nutrition 0.000 claims description 13
- 239000011718 vitamin C Substances 0.000 claims description 13
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 12
- 235000013871 bee wax Nutrition 0.000 claims description 12
- 239000012166 beeswax Substances 0.000 claims description 12
- 239000003292 glue Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 229940083466 soybean lecithin Drugs 0.000 claims description 11
- 239000000725 suspension Substances 0.000 claims description 10
- 239000003755 preservative agent Substances 0.000 claims description 9
- 230000002335 preservative effect Effects 0.000 claims description 9
- 239000000084 colloidal system Substances 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000009413 insulation Methods 0.000 claims description 5
- 230000007246 mechanism Effects 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 229910001220 stainless steel Inorganic materials 0.000 claims description 5
- 239000010935 stainless steel Substances 0.000 claims description 5
- 230000009466 transformation Effects 0.000 claims description 5
- 238000010792 warming Methods 0.000 claims description 5
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 4
- 240000005809 Prunus persica Species 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 7
- 230000036737 immune function Effects 0.000 abstract description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract description 6
- 230000002490 cerebral effect Effects 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000001151 other effect Effects 0.000 abstract description 3
- 208000017667 Chronic Disease Diseases 0.000 abstract description 2
- 230000015015 brainstem development Effects 0.000 abstract description 2
- 235000012041 food component Nutrition 0.000 abstract description 2
- 230000008271 nervous system development Effects 0.000 abstract description 2
- 241000208689 Eucommia ulmoides Species 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 235000010215 titanium dioxide Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
- 238000003304 gavage Methods 0.000 description 27
- 229940024606 amino acid Drugs 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 11
- 229910052791 calcium Inorganic materials 0.000 description 11
- 239000011575 calcium Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- CUXYLFPMQMFGPL-BGDVVUGTSA-N (9Z,11E,13Z)-octadecatrienoic acid Chemical group CCCC\C=C/C=C/C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-BGDVVUGTSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 235000021388 linseed oil Nutrition 0.000 description 4
- 239000000944 linseed oil Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000006303 photolysis reaction Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 3
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229940108924 conjugated linoleic acid Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007087 memory ability Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 208000007442 rickets Diseases 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- CUXYLFPMQMFGPL-UYWAGRGNSA-N trichosanic acid Natural products CCCCC=C/C=C/C=CCCCCCCCC(=O)O CUXYLFPMQMFGPL-UYWAGRGNSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000251123 Mustelus antarcticus Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- XJHLJVVLRQXMQI-UHFFFAOYSA-N [Ca].C(C(=O)O)(=O)O Chemical compound [Ca].C(C(=O)O)(=O)O XJHLJVVLRQXMQI-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003026 anti-oxygenic effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- -1 i.e. Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002294 pubertal effect Effects 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 维生素D3残存率(%) |
对照组 | 74.2 |
实施例1组 | 96.2 |
实施例2组 | 98.1 |
实施例3组 | 95.5 |
对比例1组 | 75.5 |
对比例2组 | 70.1 |
组别 | N(只) | 剂量(mg/kg) | 胸腺重量(mg/10g体重) | 脾脏腺重量(mg/10g体重) |
模型组 | 10 | - | 27.52±10.36 | 57.34±22.65 |
高剂量组 | 10 | 45 | 35.28±14.07▲▲ | 63.12±25.09▲▲ |
中剂量组 | 10 | 22.5 | 32.17±12.51▲▲ | 61.29±24.39▲▲ |
低剂量组 | 10 | 11.5 | 28.39±11.35 | 58.30±23.18 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510859340.4A CN105476020B (zh) | 2015-11-30 | 2015-11-30 | 一种维生素d3软胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510859340.4A CN105476020B (zh) | 2015-11-30 | 2015-11-30 | 一种维生素d3软胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105476020A CN105476020A (zh) | 2016-04-13 |
CN105476020B true CN105476020B (zh) | 2018-05-15 |
Family
ID=55663592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510859340.4A Active CN105476020B (zh) | 2015-11-30 | 2015-11-30 | 一种维生素d3软胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105476020B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106387864A (zh) * | 2016-08-18 | 2017-02-15 | 安士生物科技(中山)有限公司 | 一种增加骨密度保健软胶囊及其制备方法 |
CN106723064B (zh) * | 2016-12-13 | 2020-06-30 | 广州富诺健康科技股份有限公司 | 一种维生素d3软胶囊及其制备方法 |
CN109464418A (zh) * | 2018-12-26 | 2019-03-15 | 广东润源中天生物科技有限公司 | 一种维生素c维生素e软胶囊及其制备方法 |
CN109602020A (zh) * | 2018-12-26 | 2019-04-12 | 广东润源中天生物科技有限公司 | 一种维生素k软胶囊及其制备方法 |
CN109662953B (zh) * | 2019-02-18 | 2022-05-10 | 威海金思力生物科技股份有限公司 | 一种维生素d软胶囊及其制作方法 |
CN111602820A (zh) * | 2020-05-28 | 2020-09-01 | 广州富诺营养科技有限公司 | 一种含有维生素a和维生素d的滴剂及其制备方法 |
NL2029172B1 (en) * | 2021-09-10 | 2023-03-21 | Liposoma Health B V | Lipid formulations for the preparation of health ingredient-containing hot drinks |
CN114468287A (zh) * | 2021-12-31 | 2022-05-13 | 天津市元生泰科技有限公司 | 一种适合于航天员体质螯合钙的配方及制备方法 |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5745415B2 (zh) * | 1977-12-19 | 1982-09-28 | ||
JPH0515691B2 (zh) * | 1986-12-29 | 1993-03-02 | Asahi Kasei Kogyo Kk | |
CN1286938A (zh) * | 2000-08-29 | 2001-03-14 | 洪中怡 | 核桃素油软胶囊食品及制备方法 |
CN1371281A (zh) * | 1999-08-31 | 2002-09-25 | 中外制药株式会社 | 软胶囊剂 |
CN1475213A (zh) * | 2003-06-26 | 2004-02-18 | 新疆特丰药业股份有限公司 | 大豆异黄酮软胶囊及其制备工艺 |
DE202006014985U1 (de) * | 2006-09-29 | 2006-11-30 | Dr. Willmar Schwabe Gmbh & Co. Kg | Zusammensetzung zur Verbesserung des Zustandes und der Gesunderhaltung von Haut und Knochen |
CN101278965A (zh) * | 2008-05-26 | 2008-10-08 | 北京星昊医药股份有限公司 | 地锦草软胶囊及其制备方法 |
CN101647810A (zh) * | 2009-09-04 | 2010-02-17 | 芜湖市诺康生物科技有限公司 | 一种液体钙软胶囊 |
CN102125581A (zh) * | 2010-01-14 | 2011-07-20 | 哈尔滨顺亿堂医药生物科技开发有限公司 | 维d钙软胶囊的制备方法 |
CN102218072A (zh) * | 2011-04-20 | 2011-10-19 | 昆明邦宇制药有限公司 | 一种治疗缺钙的药物组合物及其制剂 |
CN103190615A (zh) * | 2013-04-03 | 2013-07-10 | 上海春芝堂生物制品有限公司 | 一种液体钙软胶囊及其制备方法 |
CN103734694A (zh) * | 2013-11-21 | 2014-04-23 | 荣成百合生物技术有限公司 | 一种补钙保健食品及其制备方法 |
CN103784419A (zh) * | 2012-10-31 | 2014-05-14 | 成都国弘医药有限公司 | 一种含有骨化三醇的软胶囊及其制备方法 |
CN104432102A (zh) * | 2014-12-03 | 2015-03-25 | 安徽哈博药业有限公司 | 一种钙维生素d软胶囊 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR102013013564A2 (pt) * | 2013-05-31 | 2015-07-07 | Ems Sa | Composição para tratamento ou redução de sintomas relacionados à tensão pré-menstrual (tpm), transtorno disfórico pré-menstrual (tdpm), pré-menopausa, menopausa ou desordens hormonais femininas, forma farmacêutica contendo dita composição, processo para produzir dita forma farmacêutica e uso de dita composição |
-
2015
- 2015-11-30 CN CN201510859340.4A patent/CN105476020B/zh active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5745415B2 (zh) * | 1977-12-19 | 1982-09-28 | ||
JPH0515691B2 (zh) * | 1986-12-29 | 1993-03-02 | Asahi Kasei Kogyo Kk | |
CN1371281A (zh) * | 1999-08-31 | 2002-09-25 | 中外制药株式会社 | 软胶囊剂 |
CN1286938A (zh) * | 2000-08-29 | 2001-03-14 | 洪中怡 | 核桃素油软胶囊食品及制备方法 |
CN1475213A (zh) * | 2003-06-26 | 2004-02-18 | 新疆特丰药业股份有限公司 | 大豆异黄酮软胶囊及其制备工艺 |
DE202006014985U1 (de) * | 2006-09-29 | 2006-11-30 | Dr. Willmar Schwabe Gmbh & Co. Kg | Zusammensetzung zur Verbesserung des Zustandes und der Gesunderhaltung von Haut und Knochen |
CN101278965A (zh) * | 2008-05-26 | 2008-10-08 | 北京星昊医药股份有限公司 | 地锦草软胶囊及其制备方法 |
CN101647810A (zh) * | 2009-09-04 | 2010-02-17 | 芜湖市诺康生物科技有限公司 | 一种液体钙软胶囊 |
CN102125581A (zh) * | 2010-01-14 | 2011-07-20 | 哈尔滨顺亿堂医药生物科技开发有限公司 | 维d钙软胶囊的制备方法 |
CN102218072A (zh) * | 2011-04-20 | 2011-10-19 | 昆明邦宇制药有限公司 | 一种治疗缺钙的药物组合物及其制剂 |
CN103784419A (zh) * | 2012-10-31 | 2014-05-14 | 成都国弘医药有限公司 | 一种含有骨化三醇的软胶囊及其制备方法 |
CN103190615A (zh) * | 2013-04-03 | 2013-07-10 | 上海春芝堂生物制品有限公司 | 一种液体钙软胶囊及其制备方法 |
CN103734694A (zh) * | 2013-11-21 | 2014-04-23 | 荣成百合生物技术有限公司 | 一种补钙保健食品及其制备方法 |
CN104432102A (zh) * | 2014-12-03 | 2015-03-25 | 安徽哈博药业有限公司 | 一种钙维生素d软胶囊 |
Non-Patent Citations (2)
Title |
---|
维生素C和维生素E抗氧化机制及其应用的研究进展;葛颖华; 钟晓明;《吉林医学》;20070520(第5期);第708页 3 维生素C和维生素E的关系 * |
葡萄精华软胶囊的制备工艺研究;卢耀勤等;《新疆医科大学学报》;20080531;第31卷(第5期);第518页左栏第1段,第519的3 讨论 * |
Also Published As
Publication number | Publication date |
---|---|
CN105476020A (zh) | 2016-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105476020B (zh) | 一种维生素d3软胶囊及其制备方法 | |
JP7265787B2 (ja) | 食餌性脂肪酸の要求を満たすための方法、組成物、及び装置 | |
CN109965026A (zh) | 一种促进儿童成长的配方奶粉及其制备方法 | |
CN108391811A (zh) | 一种肿瘤全营养配方食品及其应用 | |
CN102429307A (zh) | 一种低热量全营养饮品及其制备方法 | |
CN108077911A (zh) | 一种癫痫患者专用型临床营养配方及其制备方法 | |
CN103431392B (zh) | 一种供糖尿病患者食用的复合海洋特膳食品 | |
CN101283797B (zh) | 以核桃油为基质的促智健脑保健品 | |
KR20140017977A (ko) | 노년층용 비타 하이브리드 정제 및 그 제조 방법 | |
CN102132821A (zh) | 配方营养米及制备方法 | |
JPH0977674A (ja) | 薬用乾燥酵母含有機能性組成物 | |
CN104543274B (zh) | 一种含dha的软糖 | |
JP2006519165A (ja) | アザラシ油ベースの脂質エマルジョン注射物、その調製および静脈注射物の調製のためのその使用 | |
CN116570028A (zh) | 一种含有燕窝酸、磷脂和多不饱和脂肪酸组合物及其制备方法 | |
CN107712909A (zh) | 一种铁锌多维口服液 | |
CN101715984B (zh) | 一种螺旋藻胶囊及其生产制作工艺 | |
WO2008140064A1 (ja) | 生活習慣病の予防および改善のための栄養組成物 | |
CN103404875B (zh) | 一种供心血管疾病患者食用的复合海洋特膳食品 | |
KR20140017976A (ko) | 수험생용 비타 하이브리드 정제 및 그 제조 방법 | |
CN109527579A (zh) | 一种奇亚籽油制品及其制备方法和该奇亚籽油制品的应用 | |
CN103690564A (zh) | 林蛙高蛋白钙粉在制备抗疲劳保健品或药物中的应用 | |
CN102763845A (zh) | 一种沙棘油蜂胶软胶囊 | |
CN104958345A (zh) | 一种具有降血脂功能的大豆卵磷脂软胶囊及其制备方法 | |
JP3816545B2 (ja) | 人工透析患者の皮膚そう痒症治療組成物及び副甲状腺機能亢進症治療組成物 | |
CN102920750A (zh) | 一种健脑明目保健复合制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 510000 Guangdong city of Guangzhou province Haizhuqu District Chang Gang Road No. 238, room 2511 International Center of dart Applicant after: GUANGZHOU FUNUO HEALTH TECHNOLOGY CO.,LTD. Address before: 510000 Guangdong city of Guangzhou province Haizhuqu District Chang Gang Road No. 238, room 2511 International Center of dart Applicant before: GUANGZHOU FUNUO BIOTECHNOLOGY Co.,Ltd. |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 3 / F, North Funuo health building, Yulu Avenue, Lankao County, Kaifeng City, Henan Province Patentee after: Funo health Co.,Ltd. Address before: 3 / F, North Funuo health building, Yulu Avenue, Lankao County, Kaifeng City, Henan Province Patentee before: Funo health (Lankao) Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 3 / F, North Funuo health building, Yulu Avenue, Lankao County, Kaifeng City, Henan Province Patentee after: Funo health (Lankao) Co.,Ltd. Address before: 510000, Guangdong Province, Haizhuqu District, Guangzhou Province, 238 Middle Road, Chang Yi dart International Center, room 2511 Patentee before: GUANGZHOU FUNUO HEALTH TECHNOLOGY Co.,Ltd. |